FDA Drug Recalls

Recalls / Class II

Class IID-0660-2023

Product

Cardioplegia Solution, Induction 8:1 High Potassium, 108 mEq K, packaged in 500 mL per bag, Rx only, Central Admixture Pharmacy Services, Inc., Lehigh Valley, 6580 Snowdrift Road, Allentown, PA 18106, NDC 71285-0102-1.

Affected lot / code info
Lot # 37-894305, Exp 04/29/2023; 37-896153, Exp 05/06/2023; 37-897073, Exp 05/11/2023; 37-897925, 37-897941, Exp 05/13/2023; 37-899607, 37-899608, Exp 05/20/2023; 37-900320, Exp 05/22/2023

Why it was recalled

Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.

Recalling firm

Firm
Central Admixture Pharmacy Services, Inc.
Notification channel
E-Mail
Type
Voluntary: Firm initiated
Address
6580 Snowdrift Rd Ste 100, N/A, Allentown, Pennsylvania 18106-9331

Distribution

Quantity
544 bags
Distribution pattern
Nationwide in the USA.

Timeline

Recall initiated
2023-04-28
FDA classified
2023-05-19
Posted by FDA
2023-05-31
Terminated
2025-06-22
Status
Terminated

Source: openFDA Drug Enforcement endpoint. Recall record D-0660-2023. The FDA issues recall classifications as health-hazard assessments, not legal findings; for legal claims consult a licensed attorney.

Class II recall: drug · FDA Drug Recalls